Arndt Vogel, Ivan Borbath, Shwetha Chiluveru, Hong Jae Chon, Yin-Hsun Feng, Natsumi Irahara, Bo Hyun Kim, Jennifer J. Knox, Masatoshi Kudo, Shi Li, Tim Meyer, Joong-Won Park, Shu-Kui Qin, Anila Tahiri, Yann Touchefeu, Bruno Sangro. "IMbrave251: Final analysis of atezolizumab (atezo) + lenvatinib (lenva) or sorafenib (sora) vs lenva or sora alone in locally advanced or metastatic hepatocellular carcinoma (LA/mHCC) previously treated with atezo and bevacizumab (bev).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4002